If animal or human studies have demonstrated fetal abnormalities and the risks clearly outweigh potential benefits, this is categorized as?

If animal or human studies have demonstrated fetal abnormalities and the risks clearly outweigh potential benefits, this is categorized as?

• A. Category A
• B. Category X
• C. Category C
• D. Category D

Answer: (B)

Understanding FDA pregnancy risk labeling helps explain why this is categorized as Category X. This category represents the strongest warning: the drug is contraindicated in pregnancy. It means that studies in animals or humans have shown fetal abnormalities or there is clear evidence of fetal risk, and the risks clearly outweigh any potential benefit to the mother. Because of that, the medication should not be used by pregnant people or those who could become pregnant, and alternatives should be sought. This category is set apart from the others (A through D), which describe varying levels of risk and possible justification, but do not state that the risk to the fetus outweighs any benefit to the patient in such definitive terms.

Understanding FDA pregnancy risk labeling helps explain why this is categorized as Category X. This category represents the strongest warning: the drug is contraindicated in pregnancy. It means that studies in animals or humans have shown fetal abnormalities or there is clear evidence of fetal risk, and the risks clearly outweigh any potential benefit to the mother. Because of that, the medication should not be used by pregnant people or those who could become pregnant, and alternatives should be sought. This category is set apart from the others (A through D), which describe varying levels of risk and possible justification, but do not state that the risk to the fetus outweighs any benefit to the patient in such definitive terms.